Company Overview and News

3
PEGI vs. VST: Which Stock Should Value Investors Buy Now?

2018-07-16 zacks
Investors with an interest in Utility - Electric Power stocks have likely encountered both Pattern Energy (PEGI - Free Report) and Vistra Energy Corp. (VST - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
VST.WSA VST GTT VSTE

0
VST / Vistra Energy Corp. 424B3 (Prospectus)

2018-07-13 sec.gov
424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-215288 Vistra Energy Corp. 168,779,076 Shares of Common Stock
VST

2
Cramer Remix: Investors can't see the reality of this market

2018-07-12 cnbc
CNBC's Jim Cramer is tired of analysts and commentators harping on how expensive the stock market has become.
LRCX VST.WSA WYNN VST WWE VSTE LVS

0
Record Summer Demand In ERCOT Will Have Vistra Energy Generating Record Profits

2018-07-09 seekingalpha
ERCOT, where Vistra generates most of its power, saw records for energy demand for the month of May.
VST.WSA VST VSTE DTK

1
VST / Vistra Energy Corp. POS AM

2018-07-02 sec.gov
POS AM Table of Contents As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-215288
VST

0
World’s Biggest Battery Proposed in California - WSJ

2018-06-30 wsj
A California utility is seeking permission to have a company build the world’s largest battery, joining a growing list of power companies investing in storing electricity.
VST.WSA VST VSTE

0
VST / Vistra Energy Corp. 8-K (Current Report)

2018-06-29 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
VST

0
VST / Vistra Energy Corp. 424B3 (Prospectus)

2018-06-29 sec.gov
424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-215288 PROSPECTUS SUPPLEMENT NO. 19 (to Prospectus dated March 21, 2018) Vistra Energy Corp.
VST

0
VST / Vistra Energy Corp. 424B3 (Prospectus)

2018-06-15 sec.gov
Document Filed Pursuant to Rule 424(b)(3) Registration No. 333-215288
VST

0
VST / Vistra Energy Corp. 424B3 (Prospectus)

2018-06-15 sec.gov
424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-215288 PROSPECTUS SUPPLEMENT NO. 18 (to Prospectus dated March 21, 2018) Vistra Energy Corp.
VST

0
VST / Vistra Energy Corp. FORM 8-K (Current Report)

2018-06-15 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
VST

0
VST / Vistra Energy Corp. 424B3 (Prospectus)

2018-06-01 sec.gov
Document Filed Pursuant to Rule 424(b)(3)
VST

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to VST / Vistra Energy Corp. on message board site Silicon Investor.

VarsityBooks.com (VSTY) National Vision Inc. (NVI - VSTA - NVAL)
Paragon Real Estate Eqty Invst EVST Everlast Worldwide Inc
VitalStream Holdings Inc. (VSTH) VSTR
VSTR: VoiceStream Wireless Corp RVST: Ravisent Technologies
VSTI HVST - Just a reporting shell.